48.48
Past performance is not a reliable indicator of future results
What is GRAIL Inc (GRAL)?
GRAIL Inc is a healthcare company specializing in early cancer detection through advanced genomic technologies. The company develops blood-based tests designed to identify multiple types of cancer at early stages by analyzing circulating tumor DNA. GRAIL's approach integrates next-generation sequencing, machine learning, and large-scale clinical studies to improve the accuracy and reliability of its diagnostic tests. The company collaborates with healthcare providers, research institutions, and regulatory agencies to validate and implement its technologies. Its mission involves transforming cancer screening and enabling earlier intervention to improve survival rates. GRAIL's operations encompass research and development, clinical validation, regulatory submissions, and commercialization efforts. The company is positioned within the broader field of liquid biopsy and precision oncology diagnostics.
GRAIL Inc Stock Price Today: Live Overview
The price today is shaped by active session trading, as Fidelity MSCI Real Estate Index ETF trades at $48.48. Price has fluctuated between $48.07 and $51.28 with a daily change of +2.1331%.
FAQ: GRAIL Inc (GRAL)
What is the current price of GRAL stock?
The last recorded price is $48.48.
Does GRAL pay dividends?
GRAIL Inc does not currently pay dividends.
Does GRAL have a formal corporate presence or regional headquarters in the UAE?
GRAIL Inc has a registered presence in the UAE through a subsidiary located in the Dubai International Financial Centre (DIFC).
What is GRAL best known for?
The company is most famous for its early cancer detection blood tests.
What assets are typically shown together with GRAL?
Commonly shown alongside GRAL: JFrog Ltd., Roblox Corp, Cerence Inc.
Latest shares articles
Ratings and Reviews
Ratings and Reviews
